Article

A vision for the world

Helping others to help themselves

Back in 2002,Max Reindl, founder and chief executive officer of Wavelight AG and his colleague, Susanne Grethlein, vice president marketing and investor relations founded the sponsoring association Vision for the World (VFTW). Its aim was, and still is, to give something back to the ophthalmic community from businesses that serve it.

"At ECWA I learnt basic history and examination of ophthalmic patients. I also learnt from weekly hospital presentations reviewing journals. I was taught simple cataract surgery and other minor surgeries like chalazion I&C, pterygyium excision and lid rotation. I personally completed 21 cataract surgeries before leaving for my Community Eye Health posting at National Eye Centre Kaduna and am doing fine."

Phase three, which currently under preparation, will see the start-up team getting initial experience using the phacoemulsifaction unit themselves. VFTW will then send out a partner doctor to provide refresher courses and regular training sessions. The aim is for this to be at the end of this year or the beginning of 2011.

The fourth and final phase will be when the start-up team have enough experience and can begin training their colleagues and incoming students in the future.

"Incentives must be created for the outstandingly trained doctors to apply their acquired professional knowledge in their home country for the benefit of the patients", says Max Reindl.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.